Nanette Hallett
Adult Health · Hyannis, MANPI 1558395970
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 500 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 500 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Johnson & Johnson$1K
- Amgen$964
- E.r. Squibb & Sons, L.L.C.$933
- Alnylam Pharmaceuticals Inc.$806
- Boehringer Ingelheim$681
- plus $5K from 24 others
What the payments were for
- Food & beverage$10,316100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 104 | $1,219 |
| Johnson & Johnson | 73 | $1,140 |
| Amgen | 36 | $964 |
| E.r. Squibb & Sons, L.L.C. | 43 | $933 |
| Alnylam Pharmaceuticals Inc. | 32 | $806 |
| Boehringer Ingelheim | 20 | $681 |
| Pfizer | 32 | $592 |
| AstraZeneca | 24 | $578 |
| Merck | 29 | $543 |
| Novo Nordisk | 15 | $459 |
| Scpharmaceuticals Inc. | 17 | $353 |
| Boston Scientific | 7 | $296 |
| Lexicon Pharmaceuticals, Inc. | 6 | $270 |
| Bayer | 12 | $251 |
| Esperion Therapeutics, Inc. | 11 | $200 |
| Heartflow, Inc. | 3 | $195 |
| Actelion Pharmaceuticals US, Inc. | 5 | $150 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $145 |
| Kowa Pharmaceuticals America, Inc. | 7 | $104 |
| Irhythm Technologies, Inc. | 1 | $92 |
| Amarin Pharma, Inc. | 4 | $78 |
| Sanofi-aventis U.S. LLC | 2 | $63 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $58 |
| Abiomed | 1 | $38 |
| Abbott | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Medicomp Inc | 1 | $22 |
| Philips North America LLC | 1 | $19 |
| Mannkind Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,334 in reported general payments places this provider in the 95th percentile of 671 adult health providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 203 | $287,018 |
| XareltoRivaroxaban | 79 | $115,913 |
| EntrestoSacubitril/Valsartan | 40 | $58,556 |
| JardianceEmpagliflozin | 20 | $24,194 |
| FarxigaDapagliflozin Propanediol | 15 | $20,055 |
| Metoprolol Succinate | 193 | $4,120 |
| Rosuvastatin Calcium | 53 | $3,163 |
| Amiodarone Hcl | 56 | $2,935 |
| Valsartan | 63 | $2,870 |
| Flecainide Acetate | 32 | $2,118 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 60 | $2,041 |
| Torsemide | 49 | $1,089 |
| Atorvastatin Calcium | 76 | $1,040 |
| ClopidogrelClopidogrel Bisulfate | 39 | $994 |
| Losartan Potassium | 84 | $958 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $592 | $287,018203 claims |
| Johnson & JohnsonXarelto | $1,140 | $115,91379 claims |
| NovartisEntresto | $1,219 | $58,55640 claims |
| Boehringer IngelheimJardiance | $681 | $24,19420 claims |
| AstraZenecaFarxiga | $578 | $20,05515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 671 adult health providers in Massachusetts.
Other adult health in Hyannis
- Kathleen Dietz LovettHyannis$123K
- Donna PotterHyannis$3K
- Krista TuckerBoston$157K
- Caitlin ReenCharlestown$89K
- Tiffini ReedyFall River$58K
- Christine AgiusBoston$32K
- Amy PierreJamaica Plain$27K
- Josie BazemoreBoston$22K
- Jill TerrienWorcester$18K
- Beverly HarrisGroton$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.